ATE538808T1 - Kombinierte dns/protein impfstoffzusammensetzungen - Google Patents

Kombinierte dns/protein impfstoffzusammensetzungen

Info

Publication number: ATE538808T1
Authority: AT; Austria
Prior art keywords: dna; combined dna; vaccine compositions; protein vaccine; combined
Prior art date: 2002-03-28

Application number

AT03720397T

Other languages

English (en)

Inventor

Hansjoerg Reimann

Reinhold Schirmbeck

Erik Lindblad

Original Assignee

Brenntag Biosector As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-28

Filing date

2003-03-28

Publication date

2012-01-15

2003-03-28 Application filed by Brenntag Biosector As filed Critical Brenntag Biosector As

2012-01-15 Application granted granted Critical

2012-01-15 Publication of ATE538808T1 publication Critical patent/ATE538808T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Microbiology (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT03720397T 2002-03-28 2003-03-28 Kombinierte dns/protein impfstoffzusammensetzungen ATE538808T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP02076276		2002-03-28
EP03075383		2003-02-10
PCT/EP2003/003353 WO2003082327A2 (en)	2002-03-28	2003-03-28	Combined dna/protein vaccine compositions

Publications (1)

Publication Number	Publication Date
ATE538808T1 true ATE538808T1 (de)	2012-01-15

Family

ID=28676388

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03720397T ATE538808T1 (de)	2002-03-28	2003-03-28	Kombinierte dns/protein impfstoffzusammensetzungen

Country Status (9)

Country	Link
US (1)	US20050129712A1 (de)
EP (1)	EP1490100B1 (de)
AT (1)	ATE538808T1 (de)
AU (1)	AU2003224017A1 (de)
CA (1)	CA2480690A1 (de)
DK (1)	DK1490100T3 (de)
ES (1)	ES2379346T3 (de)
IL (1)	IL164256A0 (de)
WO (1)	WO2003082327A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUE049669T2 (hu)	2011-02-11	2020-10-28	Univ Pennsylvania	Hepatitis B vírus magfehérjéjét kódoló nukleinsav-molekula és azt tartalmazó oltóanyag
US9238679B2 (en)	2011-02-11	2016-01-19	The Trustees Of The University Of Pennslyvania	Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
CN111388662B (zh) *	2020-03-12	2023-03-10	潍坊华英生物科技有限公司	一种小鹅瘟病毒的复合疫苗及卵黄抗体制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0835663T3 (da) *	1992-05-23	2010-02-01	Glaxosmithkline Biolog Sa	Kombinerede vacciner omfattende Hepatitis B overfladeantigen og andre antigener
DK0880360T3 (da) *	1996-02-12	2003-01-27	Ml Lab Plc	Hidtil ukendte fremgangsmåder til vaccination og vacciner dertil, hvilke vacciner omfatter en nucleinsyre, der koder en første epitop, og et peptid, der indeholder en sekundær epitop
GB9726555D0 (en) *	1997-12-16	1998-02-11	Smithkline Beecham Plc	Vaccine
JP2002520299A (ja) *	1998-07-09	2002-07-09	メルクエンドカムパニーインコーポレーテッド	ポリヌクレオチドワクチン配合物
GB9910375D0 (en) *	1999-05-05	1999-06-30	Lindahl Gunnar	Vaccine composition

2003
- 2003-03-28 AT AT03720397T patent/ATE538808T1/de active
- 2003-03-28 IL IL16425603A patent/IL164256A0/xx unknown
- 2003-03-28 WO PCT/EP2003/003353 patent/WO2003082327A2/en not_active Application Discontinuation
- 2003-03-28 US US10/509,498 patent/US20050129712A1/en not_active Abandoned
- 2003-03-28 DK DK03720397.3T patent/DK1490100T3/da active
- 2003-03-28 AU AU2003224017A patent/AU2003224017A1/en not_active Abandoned
- 2003-03-28 CA CA002480690A patent/CA2480690A1/en not_active Abandoned
- 2003-03-28 ES ES03720397T patent/ES2379346T3/es not_active Expired - Lifetime
- 2003-03-28 EP EP03720397A patent/EP1490100B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP1490100B1 (de)	2011-12-28
WO2003082327A2 (en)	2003-10-09
US20050129712A1 (en)	2005-06-16
EP1490100A2 (de)	2004-12-29
IL164256A0 (en)	2005-12-18
DK1490100T3 (da)	2012-03-12
WO2003082327A3 (en)	2004-03-04
CA2480690A1 (en)	2003-10-09
ES2379346T3 (es)	2012-04-25
AU2003224017A1 (en)	2003-10-13

Similar Documents

Publication	Publication Date	Title
EP3294326B1 (de)	2021-04-21	Prime-boost-schemata mit verabreichung von mindestens einem mrna-konstrukt
DE60039198D1 (de)	2008-07-24	Adjuvanszusammensetzungen zur Erhöhung der Immunantwort bezüglich Polynukleotid-basierenden Impfstoffen
NO20023829D0 (no)	2002-08-13	Proteosom influensavaksine
DK1487485T3 (da)	2011-03-14	Imidazoquinolinadjuvanser til DNA-vacciner
BRPI0518146A (pt)	2008-10-28	kit de partes, uso de um adenovìrus recombinante defectivo na replicação, e, método de vacinação de um mamìfero para a infecção por malária
DE122011100053I1 (de)	2012-03-15	Influenza vakzinzusammensetzungen zur intradermaler verabreichung.
BRPI0607840A2 (pt)	2009-06-13	uso de uma composição imunogência, e de um antìgeno de vzv, vacina ou composição imunogênica, e, kit
IL187616A (en)	2014-02-27	Use of an adjuvant compound containing polyinosinic acid – polycytidylic acid, antibiotics, and positive ion as an immunosuppressant
AR014182A1 (es)	2001-02-07	Composiciones de vacunas utiles para el tratamiento o profilaxis de tumores o lesiones inducidas por hpv; procedimiento para prevenir o tratar tumoresinducidos por hpv y procedimiento para preparar dichas composiciones
WO2007024941A3 (en)	2010-01-28	Polyvalent vaccine
BR0311995A (pt)	2005-04-05	Partìculas semelhantes a vìrus empacotadas para o uso como adjuvantes: método de preparação e uso
RU2009144125A (ru)	2011-07-27	Виросомы, содержащие гемагглютинин, полученный из вируса гриппа, вырабатываемого в клеточной линии; композиции, методы получения и применение на их основе
WO2002087494A3 (en)	2003-05-08	Novel vaccine
TW200510538A (en)	2005-03-16	Functionally reconstituted viral membranes containing adjuvant
DE69828182D1 (de)	2005-01-20	Polynukleotid-impfstoff-formulierungen
ATE538808T1 (de)	2012-01-15	Kombinierte dns/protein impfstoffzusammensetzungen
WO2003080112A3 (en)	2003-11-06	Imidazoquinolineamines as adjuvants in hiv dna vaccination
CO5300406A1 (es)	2003-07-31	Vacuna
WO2004007726A3 (en)	2004-02-19	Brachyspira hyodysenteriae vaccine
WO2007028985A3 (en)	2007-05-03	Adjuvanted vaccine
DK1227840T3 (da)	2008-02-04	Adjuverede, genetiske vacciner
DE69942161D1 (de)	2010-04-29	Genetische Adjuvanz-Impfstoffe
WO2005007691A3 (en)	2005-08-18	East coast fever vaccine based on ctl-specific schizont antigens
EP1721618A3 (de)	2007-01-10	Proteasom-influenzavirus-impfstoffzusammensetzung